Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 17 studies | 32% ± 12% | |
glutamatergic neuron | 12 studies | 49% ± 23% | |
oligodendrocyte precursor cell | 8 studies | 25% ± 10% | |
GABAergic neuron | 8 studies | 42% ± 22% | |
interneuron | 7 studies | 41% ± 19% | |
retinal rod cell | 7 studies | 26% ± 7% | |
neuron | 6 studies | 33% ± 8% | |
retinal cone cell | 6 studies | 37% ± 17% | |
epithelial cell | 4 studies | 28% ± 7% | |
GABAergic interneuron | 3 studies | 30% ± 5% | |
granule cell | 3 studies | 21% ± 4% | |
neural progenitor cell | 3 studies | 31% ± 5% | |
ependymal cell | 3 studies | 46% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2523.61 | 180 / 180 | 99% | 13.43 | 425 / 430 |
brain | 99% | 2385.31 | 2617 / 2642 | 99% | 16.30 | 701 / 705 |
prostate | 100% | 1252.82 | 245 / 245 | 94% | 6.09 | 474 / 502 |
thymus | 100% | 1104.91 | 652 / 653 | 87% | 5.11 | 528 / 605 |
adrenal gland | 97% | 725.31 | 250 / 258 | 83% | 4.63 | 192 / 230 |
esophagus | 92% | 927.90 | 1325 / 1445 | 87% | 6.90 | 160 / 183 |
stomach | 99% | 802.22 | 355 / 359 | 80% | 5.30 | 228 / 286 |
bladder | 100% | 835.38 | 21 / 21 | 72% | 3.95 | 365 / 504 |
skin | 82% | 473.92 | 1488 / 1809 | 81% | 4.83 | 381 / 472 |
intestine | 88% | 749.74 | 850 / 966 | 73% | 3.73 | 386 / 527 |
kidney | 97% | 548.24 | 86 / 89 | 61% | 2.31 | 547 / 901 |
breast | 68% | 611.62 | 314 / 459 | 83% | 5.13 | 933 / 1118 |
uterus | 99% | 979.42 | 169 / 170 | 43% | 2.84 | 198 / 459 |
pancreas | 98% | 595.92 | 320 / 328 | 38% | 1.55 | 67 / 178 |
lung | 67% | 283.80 | 390 / 578 | 67% | 3.33 | 771 / 1155 |
blood vessel | 88% | 1782.91 | 1180 / 1335 | 0% | 0 | 0 / 0 |
muscle | 61% | 244.21 | 490 / 803 | 0% | 0 | 0 / 0 |
heart | 56% | 225.50 | 482 / 861 | 0% | 0 | 0 / 0 |
adipose | 52% | 247.18 | 630 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 45% | 1.67 | 36 / 80 |
spleen | 37% | 132.75 | 88 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 31% | 1.02 | 9 / 29 |
tonsil | 0% | 0 | 0 / 0 | 29% | 1.20 | 13 / 45 |
peripheral blood | 20% | 284.45 | 182 / 929 | 0% | 0 | 0 / 0 |
liver | 7% | 20.08 | 15 / 226 | 5% | 0.17 | 22 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
GO_1900118 | Biological process | negative regulation of execution phase of apoptosis |
GO_1904693 | Biological process | midbrain morphogenesis |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0045976 | Biological process | negative regulation of mitotic cell cycle, embryonic |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0036515 | Biological process | serotonergic neuron axon guidance |
GO_0097475 | Biological process | motor neuron migration |
GO_0036514 | Biological process | dopaminergic neuron axon guidance |
GO_0061549 | Biological process | sympathetic ganglion development |
GO_0030182 | Biological process | neuron differentiation |
GO_0071679 | Biological process | commissural neuron axon guidance |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0036342 | Biological process | post-anal tail morphogenesis |
GO_0033278 | Biological process | cell proliferation in midbrain |
GO_0001843 | Biological process | neural tube closure |
GO_0001942 | Biological process | hair follicle development |
GO_0042472 | Biological process | inner ear morphogenesis |
GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0001736 | Biological process | establishment of planar polarity |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0032433 | Cellular component | filopodium tip |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0009986 | Cellular component | cell surface |
GO_0048786 | Cellular component | presynaptic active zone |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FZD3 |
Protein name | Frizzled class receptor 3 Frizzled-3 (Fz-3) (hFz3) |
Synonyms | |
Description | FUNCTION: Receptor for Wnt proteins. Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. Activation by Wnt5A stimulates PKC activity via a G-protein-dependent mechanism. Involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Plays a role in controlling early axon growth and guidance processes necessary for the formation of a subset of central and peripheral major fiber tracts. Required for the development of major fiber tracts in the central nervous system, including: the anterior commissure, the corpus callosum, the thalamocortical, corticothalamic and nigrostriatal tracts, the corticospinal tract, the fasciculus retroflexus, the mammillothalamic tract, the medial lemniscus, and ascending fiber tracts from the spinal cord to the brain. In the peripheral nervous system, controls axon growth in distinct populations of cranial and spinal motor neurons, including the facial branchimotor nerve, the hypoglossal nerve, the phrenic nerve, and motor nerves innervating dorsal limbs. Involved in the migration of cranial neural crest cells. May also be implicated in the transmission of sensory information from the trunk and limbs to the brain. Controls commissural sensory axons guidance after midline crossing along the anterior-posterior axis in the developing spinal cord in a Wnt-dependent signaling pathway. Together with FZD6, is involved in the neural tube closure and plays a role in the regulation of the establishment of planar cell polarity (PCP), particularly in the orientation of asymmetric bundles of stereocilia on the apical faces of a subset of auditory and vestibular sensory cells located in the inner ear. Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle in a beta-catenin-dependent manner (By similarity). . |
Accessions | E5RGI9 Q9NPG1 ENST00000523546.1 ENST00000240093.8 [Q9NPG1-1] ENST00000537916.2 [Q9NPG1-1] |